• Something wrong with this record ?

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

MHM. Oonk, F. Planchamp, P. Baldwin, M. Bidzinski, M. Brännström, F. Landoni, S. Mahner, U. Mahantshetty, M. Mirza, C. Petersen, D. Querleu, S. Regauer, L. Rob, R. Rouzier, E. Ulrikh, J. van der Velden, I. Vergote, L. Woelber, AGJ. van der Zee,

. 2017 ; 27 (4) : 832-837.

Language English Country United States

Document type Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't

OBJECTIVE: The aim of this study was to develop clinically relevant and evidence-based guidelines as part of European Society of Gynaecological Oncology's mission to improve the quality of care for women with gynecologic cancers across Europe. METHODS: The European Society of Gynaecological Oncology Council nominated an international development group made of practicing clinicians who provide care to patients with vulvar cancer and have demonstrated leadership and interest in the management of patients with vulvar cancer (18 experts across Europe). To ensure that the statements are evidence based, the current literature identified from a systematic search has been reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group (expert agreement). The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 181 international reviewers including patient representatives independent from the development group. RESULTS: The guidelines cover diagnosis and referral, preoperative investigations, surgical management (local treatment, groin treatment including sentinel lymph node procedure, reconstructive surgery), radiation therapy, chemoradiation, systemic treatment, treatment of recurrent disease (vulvar recurrence, groin recurrence, distant metastases), and follow-up.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010643
003      
CZ-PrNML
005      
20200513231209.0
007      
ta
008      
180404s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/IGC.0000000000000975 $2 doi
035    __
$a (PubMed)28441255
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Oonk, Maaike H M $u 1 University Medical Center, Groningen, the Netherlands. 2 Institut Bergonié, Bordeaux, France. 3 Addenbrooke's Hospital, Cambridge, United Kingdom. 4 Hollycross Oncology Center, Kielce, Poland. 5 University of Gothenburg, Gothenburg, Sweden. 6 European Institute of Oncology, Milano, Italy. 7 University of Munich, Munich, Germany. 8 Tata Memorial Hospital, Mumbai, India. 9 Medical University, Graz, Austria. 10 Charles University, Prague, Czech Republic. 11 Pierre and Marie Curie University, Paris, France. 12 St Petersburg N. N. Petrov Research Institute, St Petersburg, Russia. 13 Academic Medical Center, Amsterdam, Netherlands. 14 University Hospital, Leuven, Belgium. 15 University Medical Center, Hamburg, Germany.
245    10
$a European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer / $c MHM. Oonk, F. Planchamp, P. Baldwin, M. Bidzinski, M. Brännström, F. Landoni, S. Mahner, U. Mahantshetty, M. Mirza, C. Petersen, D. Querleu, S. Regauer, L. Rob, R. Rouzier, E. Ulrikh, J. van der Velden, I. Vergote, L. Woelber, AGJ. van der Zee,
520    9_
$a OBJECTIVE: The aim of this study was to develop clinically relevant and evidence-based guidelines as part of European Society of Gynaecological Oncology's mission to improve the quality of care for women with gynecologic cancers across Europe. METHODS: The European Society of Gynaecological Oncology Council nominated an international development group made of practicing clinicians who provide care to patients with vulvar cancer and have demonstrated leadership and interest in the management of patients with vulvar cancer (18 experts across Europe). To ensure that the statements are evidence based, the current literature identified from a systematic search has been reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group (expert agreement). The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 181 international reviewers including patient representatives independent from the development group. RESULTS: The guidelines cover diagnosis and referral, preoperative investigations, surgical management (local treatment, groin treatment including sentinel lymph node procedure, reconstructive surgery), radiation therapy, chemoradiation, systemic treatment, treatment of recurrent disease (vulvar recurrence, groin recurrence, distant metastases), and follow-up.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gynekologie $x metody $x normy $7 D006176
650    _2
$a lidé $7 D006801
650    _2
$a lékařská onkologie $x metody $x normy $7 D008495
650    _2
$a směrnice pro lékařskou praxi jako téma $7 D017410
650    _2
$a nádory vulvy $x diagnóza $x patologie $x chirurgie $x terapie $7 D014846
655    _2
$a časopisecké články $7 D016428
655    _2
$a směrnice pro lékařskou praxi $7 D017065
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Planchamp, François
700    1_
$a Baldwin, Peter
700    1_
$a Bidzinski, Mariusz
700    1_
$a Brännström, Mats, $d 1958- $7 xx0245985
700    1_
$a Landoni, Fabio
700    1_
$a Mahner, Sven
700    1_
$a Mahantshetty, Umesh
700    1_
$a Mirza, Mansoor
700    1_
$a Petersen, Cordula
700    1_
$a Querleu, Denis
700    1_
$a Regauer, Sigrid
700    1_
$a Rob, Lukas
700    1_
$a Rouzier, Roman
700    1_
$a Ulrikh, Elena
700    1_
$a van der Velden, Jacobus
700    1_
$a Vergote, Ignace
700    1_
$a Woelber, Linn
700    1_
$a van der Zee, Ate G J
773    0_
$w MED00009896 $t International journal of gynecological cancer official journal of the International Gynecological Cancer Society $x 1525-1438 $g Roč. 27, č. 4 (2017), s. 832-837
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28441255 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20200513231220 $b ABA008
999    __
$a ok $b bmc $g 1288128 $s 1007455
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 27 $c 4 $d 832-837 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...